April 4 (Reuters) - Australian Competition and Consumer Commission (ACCC):
- WILL NOT OPPOSE REVISED COCHLEAR, OTICON TRANSACTION
- CONSIDERS IT UNLIKELY THAT OTICON MEDICAL WOULD HAVE BECOME A STRONGER COMPETITOR IN SUPPLY OF COCHLEAR IMPLANTS IN FORESEEABLE FUTURE
- SATISFIED THAT ITS COMPETITION CONCERNS WITH RESPECT TO BONE CONDUCTION SOLUTIONS ARE ADDRESSED
(([email protected];))
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
4.170(1.33%) |
Mkt cap ! $20.73B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.91 | $313.71 | $43.40M | 137.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 324 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.18 | 55 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |